The US Beta-Glucan market is experiencing robust growth, driven by increasing demand in nutraceutical, pharmaceutical, and food & beverage sectors. Beta-Glucan, known for its health benefits such as immune enhancement and cholesterol reduction, is gaining traction among health-conscious consumers and manufacturers seeking natural functional ingredients for product innovation.
The economic impact of tariffs on "US Beta-Glucan Market".
Market Growth Drivers
Rising Demand for Functional Foods: As American consumers increasingly prioritize health and wellness, the demand for functional foods fortified with natural immune boosters like beta-glucan is surging. Companies such as Cargill have expanded their beta-glucan product offerings for use in breakfast cereals, beverages, and snacks, driving market traction.
Increasing Applications in Pharmaceuticals: The pharmaceutical sector in the US is leveraging beta-glucan for its scientifically-proven immune-supporting and cholesterol-lowering properties. For instance, Kerry Group announced in early 2024 the commercial launch of a new yeast beta-glucan ingredient tailored for dietary supplements and pharmaceutical formulations, expanding its footprint in the health and wellness segment.
Latest Market Trends
Clean Label and Plant-Based Movement: The surge in demand for plant-based, clean-label ingredients is influencing manufacturers to formulate products with oat and barley-derived beta-glucans. Tate & Lyle launched a new line of plant-based beta-glucans earlier this year, targeting brands looking to align with the clean-label and vegan trends.
Technological Advancements in Extraction: Recent innovations in extraction technologies allow for the production of highly pure and bioavailable beta-glucans. A leading biotech firm, Biothera Pharmaceuticals, recently announced a patented process for yeast beta-glucan extraction, enhancing ingredient efficacy and enabling new applications in functional beverages and medical nutrition.
Market Opportunities
Expansion in Sports Nutrition: The evolving US sports nutrition market presents significant opportunities for beta-glucan ingredient suppliers, with sports drinks and protein bars incorporating beta-glucan for performance and immune support. Glanbia Nutritionals is actively investing in beta-glucan-enriched sports supplement lines.
Personalized Nutrition Solutions: The momentum toward personalized nutrition opens avenues for customized beta-glucan blends targeting specific demographics, such as elderly populations or those with specific health conditions. Companies like DSM are collaborating with digital health platforms to integrate beta-glucan into targeted wellness regimens.
US Beta-Glucan Market Revenue (USD Million), 2020-2035
The US Beta-Glucan market has shown consistent year-over-year revenue growth from USD 162 million in 2020, projected to reach around USD 400 million by 2035. The chart illustrates significant acceleration between 2024 and 2030, supported by increasing consumer awareness and product launches. After 2030, growth is expected to stabilize but remain robust as beta-glucan formulations become mainstream in multiple application areas. The forecasted CAGR for the period 2024-2035 is approximately 8.2%, reflecting widespread industry adoption and innovation.
US Beta-Glucan Market by Region Share (%), 2025
In 2025, the East Coast region leads the US Beta-Glucan market, reflecting a 34% share, driven by high health-conscious populations and a concentration of nutraceutical companies. The Midwest holds 27%, supported by its robust agricultural and food processing industries. The West Coast ranks third with 21%, followed closely by the South at 13%. The Mountain Region, with emerging players and growing demand, holds the remaining 5%. This regional distribution underscores the market’s strong foundation in areas with advanced food technology infrastructure and proactive health trends.
Recent Developments in the US Beta-Glucan Market (Past 6 Months)
In February 2024, Cargill announced a strategic partnership with a leading dietary supplement company to co-develop a new range of oat beta-glucan supplements targeting cardiovascular health. This collaboration aims to accelerate the commercial rollout of clean-label, science-backed health products.
In April 2024, Kerry Group launched Wellmune® Ultra, a next-generation yeast beta-glucan ingredient with improved solubility for use in ready-to-drink beverages and dairy alternatives. The innovation enables broader product applications and enhances consumer convenience while maintaining immune support benefits.
In May 2024, DSM unveiled its personalized beta-glucan ingredient range, leveraging AI-driven health insights to tailor beta-glucan formulations to individual consumer needs. This move reinforces DSM's commitment to personalized nutrition and marks a pioneering step in ingredient customization within the US market.
Press Releases